Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dying and defibrillation: a shocking experience.

Vinod Nambisan1, David Chao

  • 1Vinod Nambisan North Middlesex University Hospital, Sterling Way, London, UK.

Palliative Medicine
|August 31, 2004
PubMed
Summary

Palliative Care physicians must consider Implantable Cardioverter Defibrillators (ICDs) in patients with terminal illnesses. Addressing ICD deactivation early prevents discomfort and ensures peaceful end-of-life care, especially outside hospitals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IgE antibody responses in cerebrospinal fluids relate to the brain pathologic injury of hosts with Angiostrongylus cantonensis infection.

Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi·2023
Same author

Stratification of PD-1 blockade response in melanoma using pre- and post-treatment immunophenotyping of peripheral blood.

Immunotherapy advances·2023
Same author

The role of immune status, viral co-infections and paraproteinemia in development of venous thromboembolism in HIV.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2022
Same author

Morbidity Patterns in Primary Care in Hong Kong: Protocol for a Practice-Based Morbidity Survey.

JMIR research protocols·2022
Same author

Metastatic melanoma patient outcomes since introduction of immune checkpoint inhibitors in England between 2014 and 2018.

International journal of cancer·2020
Same author

I-O Optimise: a novel multinational real-world research platform in thoracic malignancies.

Future oncology (London, England)·2019

Area of Science:

  • Palliative Medicine
  • Cardiology
  • Oncology

Background:

  • Palliative Care physicians manage complex comorbidities.
  • Terminal metastatic lung carcinoma presents significant end-of-life care challenges.
  • Implantable Cardioverter Defibrillators (ICDs) are increasingly common in patients with advanced disease.

Observation:

  • A case report details a patient with terminal lung cancer and an ICD.
  • The ICD's function may interfere with a comfortable, peaceful death.
  • Practical challenges in deactivating ICDs, particularly in emergencies and non-hospital settings, are highlighted.

Findings:

  • The presence of an ICD can complicate end-of-life care for terminally ill patients.
  • Deactivation of ICDs is a crucial consideration for achieving a comfortable death.
  • Early discussion and planning for ICD deactivation are essential.

Implications:

  • Proactive management of ICDs in palliative care is necessary.
  • Healthcare providers should initiate conversations about ICD deactivation with patients early in their terminal illness trajectory.
  • Addressing ICD deactivation can improve the quality of end-of-life care and patient comfort.

Related Experiment Videos